Sarah E. Hoffe, MD, on Pancreatic Cancer and SBRT: Pros and Cons

2017 Gastrointestinal Cancers Symposium
Tweet this page

Sarah E. Hoffe, MD, of the Moffitt Cancer Center, discusses the controversial role of radiation in the treatment of pancreatic cancer, recent advances in delivering short courses of high-dose stereotactic body radiation therapy, and how best to integrate this new modality in borderline and locally advanced disease.

Advertisement

Advertisement



Advertisement